Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117673304 | 11767330 | 4 | F | 20160629 | 20151123 | 20160705 | PER | US-PFIZER INC-2015398675 | PFIZER | 0.00 | F | Y | 0.00000 | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117673304 | 11767330 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | Y | 203214 | TABLET | |||||||||
| 117673304 | 11767330 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Y | 203214 | TABLET | ||||||||||
| 117673304 | 11767330 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | Y | 11719 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117673304 | 11767330 | 1 | Rheumatoid arthritis |
| 117673304 | 11767330 | 2 | Sjogren's syndrome |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117673304 | 11767330 | Abdominal discomfort | |
| 117673304 | 11767330 | Dizziness | |
| 117673304 | 11767330 | Nausea | |
| 117673304 | 11767330 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |